openPR Logo
Press release

Myocardial Ischemia Market Leading Players to Focusing More on R&D Activities for Better Result.

11-20-2018 12:55 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Market Research Future (MRFR) states in its extensive report that the global myocardial ischemia market is set to reach a worth of USD 50,120.3 million during the forecast period (2017-2023). The increasing cases of coronary artery disease and diabetes coupled with growing obesity globally are driving the market growth. On top of that, growing awareness related to heart conditions, technological advancement in treatments, and rising numbers of hospitals and healthcare infrastructure around the globe have propelled the myocardial ischemia market expansion. Moreover, strong economic growth, disposable incomes of patients, and improved standard of living can fuel the market growth over the forecast period.

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/5811

On the other hand, high cost of therapeutic surgeries impedes the market growth. However, the World Health Organization (WHO) has been actively launching new initiatives related to heart diseases which will, in turn, increase awareness and enlighten citizens on matters of heart health. Various government drives and initiatives are being implemented to address issues arising from obesity and substance abuse. These actions undertaken by authorities act as necessary incentive for the global market growth.

Growing trend in the myocardial ischemia market is increasing usage of myocardial perfusion imaging. It is a stress test which relies on imaging of a patient’s heart before and after physical activity to determine the effects of stress on the flow of blood through the coronary arteries and the heart muscle.

Global Market for Myocardial Ischemia – Segmental Analysis
The global myocardial ischemia market is segmented on the basis of type, diagnosis & treatment, and end-user.

By type, the market is segmented on the basis of symptomatic and asymptomatic. The asymptomatic (silent) myocardial ischemia segment accounted for the largest market share in 2017. Growing number of smokers, family history of heart diseases, prevalence of cases of high cholesterol and high blood pressure, and lack of exercise can drive the growth in the segment.

By treatment & diagnosis, the market is segmented into treatment and diagnosis. The diagnosis segment is sub-segmented into imaging and stress test. On the other hand, the treatment segment is sub-segmented into medications and surgery. The treatment segment has gained significant traction owing to increasing prevalence of coronary heart disease and large population leading a stressful lifestyle. Thus, the treatment segment is estimated to hold largest market share till the end of the forecast period.

The end-users in the global myocardial ischemia market are hospitals & clinics, diagnostic centers, ambulatory surgery centers, and others.

Regional Outlook
Geographically, the global myocardial ischemia market is spread across the Americas, Europe, Asia Pacific, and the Middle East and Africa.

MRFR noted that the Americas accounted for the largest market share and will maintain its dominance throughout the forecast period. The Americas market is presumed to reach USD 18,130.3 million by 2023 at a CAGR of 6.21% from 2017 to 2023. This position was achieved due to rising prevalence of diabetes, obesity, lack of physical inactivity, and excessive alcohol consumption among the population in the region.

After America, Europe holds the largest market share owing to high number of cases related to cardiovascular diseases. Revolutionary technology, rising healthcare infrastructure, continuous researches conducted to enhance treatment procedures, and easy access to medical facilities and medication has led to market growth in the region. Moreover, obesity and stressful schedules have given way to expansion of the market considerably.

Asia Pacific is expected to garner high revenues at the fastest growth rate of about 6.42% during the forecast period due to rising prevalence of diabetes. Growing awareness about cardiovascular diseases and increasing geriatric population are major driving factors of the market in the region. Moreover, growing economies in the region and rising investments in healthcare facilities along with a growing number of hospitals make sure that the market gains significant traction in the region. Apart from these factors, government initiatives to generate awareness and knowledge regarding health issues also propel the market growth.

The Middle East and Africa market is estimated to witness passive growth, which can be attributed to less exposure and access to healthcare services and stringent government rules and regulations. Moreover, substandard healthcare infrastructure can deter the growth of the market in the region.

Global Market for the myocardial ischemia market – Competitive Dashboard
Boehringer Ingelheim International GmbH,
Bayer AG,
AstraZeneca,
Taxus Cardium,
ViroMed Co. Ltd.,
Daiichi Sankyo Company Limited.

Table of Content: Key Points
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
6 Global Myocardial Ischemia Market, by Type
7 Global Myocardial Ischemia Market, by Treatment & Diagnosis
8 Global Myocardial Ischemia Market, by End User
9 Global Myocardial Ischemia Market, by Region
10 Competitive Landscape
11 Company Profiles
12 Appendix
…Continued

Access full report now: https://www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myocardial Ischemia Market Leading Players to Focusing More on R&D Activities for Better Result. here

News-ID: 1385473 • Views: …

More Releases from Market Research Future

Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics Market | Global Market Analysis Report - 2035
Ophthalmic Topical Therapeutics: Advancing Eye Care Through Targeted Treatment Ophthalmic topical therapeutics have become a cornerstone in modern eye care, offering precise, localized treatment for a wide range of ocular conditions. Unlike systemic medications, which circulate throughout the body and may produce unintended side effects, topical therapies deliver active compounds directly to the eye, ensuring higher efficacy and a faster onset of action. This localized approach not only improves treatment outcomes…
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps Market Share, Size, Growth and Forecast to 2035
Mental Health Apps: Transforming the Way We Care for Our Minds In recent years, mental health has gained increasing recognition as an essential component of overall well-being. Despite growing awareness, many individuals still face barriers to accessing mental health support, including stigma, cost, and geographic limitations. Mental health apps have emerged as a transformative solution, leveraging technology to provide accessible, personalized, and convenient mental health care for millions worldwide. The Rise of…
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves Market Size, Share, Growth | CAGR of 4.95%
Surgical Gloves: A Critical Component of Modern Healthcare Surgical gloves have become an indispensable element in modern healthcare, serving as a first line of defense against contamination, infection, and disease transmission. These gloves are not just protective gear-they are a symbol of safety, hygiene, and precision in medical practice. Their significance spans from routine hospital procedures to complex surgical interventions, highlighting their essential role in patient care and medical safety protocols. The…
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market Size, Share & Growth Report by 2035
Asia Pacific CRO Market: Driving Innovation and Transformation in the Clinical Research Landscape The Asia Pacific Contract Research Organization (CRO) market has been witnessing significant growth over the past decade, emerging as a pivotal hub for clinical research and drug development. With a growing population, increasing prevalence of chronic diseases, and rising investments in healthcare infrastructure, the region has become an attractive destination for pharmaceutical and biotechnology companies seeking cost-effective and…

All 5 Releases


More Releases for Myocardial

Driving Myocardial Infarction Market Growth in 2025: The Role of Increasing Numb …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Myocardial Infarction Market Size Growth Forecast: What to Expect by 2025? Over the past few years, there has been a significant rise in the size of the myocardial infarction market. It is projected to expand from $2.05 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual…
Diabetes Epidemic Fuels Myocardial Ischemia Market Growth: An Emerging Driver Tr …
The Myocardial Ischemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Myocardial Ischemia Market? The myocardial ischemia market has grown strongly. It will grow from $0.79 billion in 2024 to $0.85 billion in 2025 at a CAGR of 7.3%.…
Transforming the Myocardial Ischemia Market in 2025: Diabetes Epidemic Fuels Myo …
What Is the Expected Size and Growth Rate of the Myocardial Ischemia Market? The market size for myocardial ischemia has demonstrated considerable growth over the last few years. There's a predicted growth from $0.79 billion in 2024 to $0.85 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The substantial growth during the historical period can be credited to the use of telemedicine and remote monitoring, the discovery…
Myocardial Infarction Treatment Market Growth and Insights 2024
"The Business Research Company recently released a comprehensive report on the Global Myocardial Infarction Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026". The Global market size of Myocardial Infarction Drugs Market was $XX…
Myocardial Ischemia - Pipeline Review, H1 2017 - Pharmaceutical Report
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm…